Why is half-life called a derived parameter?

Half-life depends on two more fundamental quantities — it lengthens as the volume of distribution increases and shortens as clearance increases — so it is calculated from them rather than measured independently.

What does clearance actually measure?

Clearance is the volume of plasma from which drug is completely and irreversibly removed per unit time; it represents the body's overall capacity to eliminate the drug and links the dose rate to the steady-state concentration.

Pharmacokinetic Parameters (Clearance, Half-Life, Volume of Distribution)

Pharmacokinetic parameters are the quantities that summarise how a drug is handled by the body. The three most fundamental are clearance, the volume of distribution, and the elimination half-life. Clearance and volume of distribution are independent primary parameters that describe elimination capacity and the extent of distribution; half-life is a derived parameter that follows from them.

Definition

Pharmacokinetic parameters are numerical descriptors of drug disposition: clearance is the volume of plasma cleared of drug per unit time; the apparent volume of distribution relates the amount of drug in the body to the plasma concentration; the elimination half-life is the time for the plasma concentration to fall by half.

Scope

The entry defines the principal pharmacokinetic parameters, distinguishes primary (independent) from derived parameters, and explains how they relate to the concentration-time curve and to exposure measures such as the area under the curve. It is a conceptual reference and does not provide dosing calculations for individuals.

Core questions

What do clearance, volume of distribution, and half-life each represent, and how are they related?
Why are clearance and volume of distribution considered primary, and half-life derived?
How do these parameters connect to the concentration-time profile and the area under the curve?
What physiological factors cause these parameters to vary between and within individuals?

Key concepts

Clearance (primary parameter)
Apparent volume of distribution (primary parameter)
Elimination half-life (derived parameter)
Elimination rate constant
Area under the concentration-time curve (AUC)
Bioavailability
Extraction ratio and flow- vs capacity-limited clearance
Steady state and accumulation

Key theories

Physiological models of hepatic clearance: The well-stirred and parallel-tube models express organ clearance in terms of organ blood flow, the unbound fraction, and intrinsic clearance, showing how blood flow limits clearance of highly extracted drugs and intrinsic metabolic capacity limits clearance of poorly extracted drugs.

Mechanisms

Clearance measures the body's capacity to remove drug, defined as the volume of plasma irreversibly cleared per unit time; it is the sum of contributions from the eliminating organs and links dose rate to steady-state concentration. The apparent volume of distribution relates the total amount of drug in the body to the measured plasma concentration and reflects how extensively the drug partitions into tissues. The elimination half-life is not independent: it increases with volume of distribution and decreases with clearance, so a change in half-life can arise from a change in either underlying parameter. Physiological clearance models express organ clearance through blood flow, unbound fraction, and intrinsic clearance, distinguishing drugs whose elimination is limited by hepatic blood flow from those limited by enzymatic capacity. Exposure over time is captured by the area under the concentration-time curve, which together with bioavailability connects dose to systemic exposure.

Clinical relevance

These parameters provide the vocabulary for describing and comparing drug exposure and for understanding how physiology and disease alter disposition; they explain, for example, why reduced clearance raises steady-state concentrations. This entry is a conceptual reference on the parameters themselves and is not a guide to calculating doses for any individual.

Evidence & guidelines

The clearance concept and its physiological models are foundational in clinical pharmacology and codified in standard pharmacokinetics texts; reviews of how parameters vary across populations, such as by sex, inform the design and interpretation of pharmacokinetic studies in drug development.

History

Early pharmacokinetics described plasma concentrations with compartmental models and rate constants, from which half-life emerged as a salient summary. The clearance concept reframed disposition in physiological terms during the 1970s: Wilkinson and Shand related hepatic clearance to blood flow, binding, and intrinsic activity, and Pang and Rowland formalised the well-stirred and parallel-tube models. This shift established clearance and volume of distribution as the primary, independent parameters, with half-life recognised as derived.

Debates

Which model best describes hepatic clearance?: The well-stirred and parallel-tube models make different assumptions about how drug concentration varies along the hepatic sinusoid and can predict different clearances for highly extracted drugs, so the choice of model remains a methodological consideration in pharmacokinetic analysis.

Key figures

Malcolm Rowland
Thomas N. Tozer
Grant R. Wilkinson
K. Sandy Pang
Leslie Z. Benet

Seminal works

wilkinson-shand-1975
pang-rowland-1977

Frequently asked questions

Why is half-life called a derived parameter?: Half-life depends on two more fundamental quantities — it lengthens as the volume of distribution increases and shortens as clearance increases — so it is calculated from them rather than measured independently.
What does clearance actually measure?: Clearance is the volume of plasma from which drug is completely and irreversibly removed per unit time; it represents the body's overall capacity to eliminate the drug and links the dose rate to the steady-state concentration.